StonvexLoading…
StonvexStonvexStonvexCore line items from BIAF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.16M | $9.36M | $2.53M | $4.80K |
Operating Income | $-10.57M | $-8.95M | $-7.97M | $-4.01M |
Net Income | $-14.91M | $-9.04M | $-7.94M | $-8.15M |
EPS (Diluted) | $-8.66 | $-22.50 | $-0.91 | $-1.81 |
Total Assets | $10.96M | $6.51M | $8.22M | $12.18M |
Total Liabilities | $3.68M | $3.91M | $3.37M | $1.14M |
Cash & Equivalents | $6.45M | $1.11M | $2.82M | $11.41M |
Free Cash Flow OCF − CapEx | $-9.39M | $-7.34M | $-6.06M | $-4.29M |
Shares Outstanding | 4.50M | 519.16K | 9.39M | 8.38M |